Belgium· BE-AMP-SAM209675-00
Subutex 8 mg
A buprenorphine product containing buprenorphine hydrochloride, registered in Belgium by Indivior Europe. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Buprenorphine is registered in 13 of 19 countries.
Countries holding a registration under ATC N07BC01 (buprenorphine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Buprenorphine · ATC N07BC01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of buprenorphine costs, country by country.
Normalised to the WHO defined daily dose (1.6 mg), the median price runs from $1.13 in Switzerland to $4.31 in Spain — a ×3.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buprenorphine · price per daily dose (1.6 mg)
USD · FX 28 Sept 2026
- ES Spain$4.31
- IT Italy$3.30
- CH Switzerland$1.13
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Buprenorphine Hydrochloride
- Manufacturer
- Indivior Europe
- Country
- Belgium (BE)
- ATC code
- N07BC01
- ATC class
- Buprenorphine
- Defined daily dose
- 1.6 mg, Implantat
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb1640598EUR 23.48
- be_apb0774224
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
376 interactions on record for buprenorphine.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buprenorphine · interactions on record
376 records
- 59 severe
- 253 moderate
- 2 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- DronabinolA04AD10severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buprenorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBuprenorphineClinical Solutions Wholesale, LLC
- United KingdomBuprenorphine 8mg sublingual tablets sugar freeG.L. Pharma UK Ltd
- CzechiaADDNOKI-GEN, LDA, Caparica
- FranceBUPENSAN 8 mg, comprimé sublingualG.L. PHARMA (AUTRICHE)
- NetherlandsBuprenorfine SUN 8 mg tabletten voor sublinguaal gebruikSun Pharmaceutical Industries Europe B.V.
- PolandBunorfinL.Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A.
- IrelandBuprenorphine 8 mg Sublingual TabletsActivase Pharmaceuticals Limited
- SwedenBuprefarm 10 mikrogram/timme DepotplåsterOrifarm Generics A/S
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- France · Bupensan, Buprenorphine Arrow
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Netherlands · Buprenorfine, Buprenorfine 1a Pharma
- Norway · Bugnanto, Buprefarm
- Poland · Bunondol, Bunorfin
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cae19b0f-7e14-44b2-8361-20a780a452e8 GET /v1/drugs/cae19b0f-7e14-44b2-8361-20a780a452e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Sublingual tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Subutex 8 mg",
"name_fr": "Subutex 8 mg",
"name_nl": "Subutex 8 mg",
"amp_code": "SAM209675-00",
"strengths": [
"8.6400",
"8.6400",
"8.0000",
"8.0000",
"120.0000",
"191.7600"
],
"pack_count": 2,
"substances": [
"Buprenorphine Hydrochloride",
"Buprenorphine",
"Mannitol",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Buprenorphine",
"authorisation_numbers": [
"BE209675"
]
}See everything about buprenorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.